Keywords: b-ms, muraglitazer, rights, returned, drug, majors, bristol-myers

B-MS's muraglitazer rights returned

Article | 09 January 2006

US drug majors Bristol-Myers Squibb and Merck & Co have reached a mutually-acceptable termination agreement, with all rights to muraglitazar, an ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Bristol-Myers Squibb

Merck

Merck KGaA

Go to company listing

Related Drugs

Nystatin

Go to drug listing